Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Allergies Health Center

Font Size

FDA Approves Clarinex-D 12 Hour

Extended-Release Treatment Approved for Seasonal Allergy Symptoms

WebMD Health News
Reviewed by Louise Chang, MD

Feb. 3, 2006 -- A newer version of the prescription allergy medicine Clarinex has been approved by the FDA to treat nasal and non-nasal symptoms of seasonal allergies including nasal congestion in adults and children over age 12.

Researchers say the new Clarinex-D 12 Hour should be available in time for the spring allergy season.

Clarinex (desloratadine) is a nonsedating antihistamine available by prescription for the treatment of seasonal allergy symptoms. Clarinex-D 24 Hour (containing 5 milligrams desloratadine and 240 milligrams pseudoephedrine) as a once-daily prescription was approved last spring.

The newly approved Clarinex-D 12 Hour contains 2.5 milligrams desloratadine and 120 milligrams pseudoephedrine. The recommended dosing would be twice a day.

The FDA based its approval on two clinical trials involving more than 1,200 people with seasonal allergies. The studies compared treatment of Clarinex-D 12 HOUR extended-release tablets with pseudoephedrine alone and desloratadine alone.

The results showed that the extended-release-combined medication effectively relieved nasal congestion as well as provided significantly greater relief than desloratadine alone and that it relieved other allergy symptoms (excluding nasal congestion) better than pseudoephedrine alone.

The most common side effects associated with Clarinex-D 12 Hour were insomnia, headache, dry mouth, and fatigue. It should not be taken by those with narrow-angle glaucoma, severe high blood pressure or heart disease, urination difficulty, or by patients who may have taken a monoamine-oxidase inhibitor within the past 14 days. Those with certain other medical conditions such as high blood pressure, diabetes, heart disease, thyroid, liver, or kidney problems, or enlarged prostate should check with their health care provider prior to using Clarinex-D 12 hour or Clarinex-D 24 Hour.

About 36 million people in the U.S. are affected by seasonal allergies. Symptoms include runny nose, sneezing, nasal congestion, and itchy, watery eyes.

Today on WebMD

man blowing nose
Make these tweaks to your diet, home, and lifestyle.
Allergy capsule
Breathe easier with these products.
cat on couch
Live in harmony with your cat or dog.
Woman sneezing with tissue in meadow
Which ones affect you?

blowing nose
woman with sore throat
lone star tick
Woman blowing nose

Send yourself a link to download the app.

Loading ...

Please wait...

This feature is temporarily unavailable. Please try again later.


Now check your email account on your mobile phone to download your new app.

cat lying on shelf
Allergy prick test
Man sneezing into tissue
Woman holding feather duster up to face, twitching